Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harm C Arentsen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
World Journal of Urology|February 17, 2009
Experimental rat bladder urothelial cell carcinoma modelsHarm C Arentsen, Kees Hendricksen, Egbert Oosterwijk, et al.
Urologic Oncology|October 22, 2013
The effect of photochemical internalization of bleomycin in the treatment of urothelial carcinoma of the bladder: an in vitro studyHarm C Arentsen, Johannes Falke, Anders Høgset, et al.
Hematology/Oncology Clinics of North America|April 4, 2015
Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinomaYme Weijers, Harm C Arentsen, Tom J H Arends, et al.
Expert Review of Molecular Diagnostics|December 26, 2006
Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancerHarm C Arentsen, Jean J M C H de la Rosette, Theo M de Reijke, et al.
Urologic Oncology|December 1, 2009
The orthotopic Fischer/AY-27 rat bladder urothelial cell carcinoma model to test the efficacy of different apaziquone formulationsHarm C Arentsen, Kees Hendricksen, Christina A Hulsbergen-van de Kaa, et al.
BJU International|February 15, 2011
Pharmacokinetics and toxicity of intravesical TMX-101: a preclinical study in pigsHarm C Arentsen, Christina A Hulsbergen-Van de Kaa, Cornelius F J Jansen, et al.
Therapeutic Advances in Urology|July 24, 2018
Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer modelF Johannes P van Valenberg, Dalit Strauss-Ayali, Yael Agmon-Gerstein, et al.
The Journal of Urology|December 5, 2012
Results of a phase 1 dose escalation study of intravesical TMX-101 in patients with nonmuscle invasive bladder cancerJohannes Falke, Rianne J M Lammers, Harm C Arentsen, et al.
The Journal of Urology|February 21, 2012
Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladderHarm C Arentsen, Cornelius F J Jansen, Christina A Hulsbergen-van de Kaa, et al.
European Urology|February 2, 2010
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendationsJ Alfred Witjes, Juan Palou Redorta, Didier Jacqmin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
World Journal of Urology|February 17, 2009
Experimental rat bladder urothelial cell carcinoma modelsHarm C Arentsen, Kees Hendricksen, Egbert Oosterwijk, et al.
Urologic Oncology|October 22, 2013
The effect of photochemical internalization of bleomycin in the treatment of urothelial carcinoma of the bladder: an in vitro studyHarm C Arentsen, Johannes Falke, Anders Høgset, et al.
Hematology/Oncology Clinics of North America|April 4, 2015
Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinomaYme Weijers, Harm C Arentsen, Tom J H Arends, et al.
Expert Review of Molecular Diagnostics|December 26, 2006
Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancerHarm C Arentsen, Jean J M C H de la Rosette, Theo M de Reijke, et al.
Urologic Oncology|December 1, 2009
The orthotopic Fischer/AY-27 rat bladder urothelial cell carcinoma model to test the efficacy of different apaziquone formulationsHarm C Arentsen, Kees Hendricksen, Christina A Hulsbergen-van de Kaa, et al.
BJU International|February 15, 2011
Pharmacokinetics and toxicity of intravesical TMX-101: a preclinical study in pigsHarm C Arentsen, Christina A Hulsbergen-Van de Kaa, Cornelius F J Jansen, et al.
Therapeutic Advances in Urology|July 24, 2018
Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer modelF Johannes P van Valenberg, Dalit Strauss-Ayali, Yael Agmon-Gerstein, et al.
The Journal of Urology|December 5, 2012
Results of a phase 1 dose escalation study of intravesical TMX-101 in patients with nonmuscle invasive bladder cancerJohannes Falke, Rianne J M Lammers, Harm C Arentsen, et al.
The Journal of Urology|February 21, 2012
Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladderHarm C Arentsen, Cornelius F J Jansen, Christina A Hulsbergen-van de Kaa, et al.
European Urology|February 2, 2010
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendationsJ Alfred Witjes, Juan Palou Redorta, Didier Jacqmin, et al.
Pageof 2